quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:54:20·27d
SECFiling
Verra Mobility Corporation logo

Amendment: SEC Form SCHEDULE 13G/A filed by Verra Mobility Corporation

VRRM· Verra Mobility Corporation
Consumer Discretionary
Original source

Companies

  • VRRM
    Verra Mobility Corporation
    Consumer Discretionary

Recent analyst ratings

  • Jan 26UpdateAnalyst$25.00
  • Apr 22UpdateRobert W. Baird$27.00
  • Oct 20UpdateUBS$25.00
  • Jul 31UpdateDeutsche Bank$26.00
  • Jul 13UpdateRobert W. Baird$18.00
  • Mar 30UpdateDeutsche Bank$17.00

Related

  • PR7d
    Verra Mobility Schedules First Quarter 2026 Earnings Call
  • PR8d
    Verra Mobility launches AutoKinex™ Virtual Agent to expedite car rental ancillary service selection with a seamless in-vehicle digital experience
  • SEC17d
    SEC Form DEFA14A filed by Verra Mobility Corporation
  • SEC17d
    SEC Form DEF 14A filed by Verra Mobility Corporation
  • INSIDER37d
    President and CEO Roberts David Martin was granted 93,362 shares and covered exercise/tax liability with 39,520 shares, increasing direct ownership by 7% to 842,569 units (SEC Form 4)
  • INSIDER37d
    Chief Legal Officer Keyser Jonathan was granted 5,334 shares and covered exercise/tax liability with 2,257 shares, increasing direct ownership by 30% to 13,448 units (SEC Form 4)
  • INSIDER37d
    EVP-Government Solutions Baldwin Jonathan was granted 21,339 shares and covered exercise/tax liability with 9,888 shares, increasing direct ownership by 43% to 37,887 units (SEC Form 4)
  • INSIDER37d
    Chief Financial Officer Conti Craig C was granted 27,741 shares and covered exercise/tax liability with 11,742 shares, increasing direct ownership by 19% to 102,409 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022